Andreas Betz

Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis

Greg Coffey, Francis DeGuzman, Mayuko Inagaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 116 citations

The Novel Kinase Inhibitor PRT062070 (Cerdulatinib) Demonstrates Efficacy in Models of Autoimmunity and B-Cell Cancer

Greg Coffey, Andreas Betz, Francis DeGuzman et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 89 citations

The Selective Syk Inhibitor P505-15 (PRT062607) Inhibits B Cell Signaling and Function In Vitro and In Vivo and Augments the Activity of Fludarabine in Chronic Lymphocytic Leukemia

Stephen E. Spurgeon, Greg Coffey, Luke B. Fletcher et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 53 citations · Full text

Efficacy of the Novel Selective Platelet-Derived Growth Factor Receptor Antagonist CT52923 on Cellular Proliferation, Migration, and Suppression of Neointima following Vascular Injury

Jin‐Chen Yu, Nathalie A. Lokker, Stanley J. Hollenbach et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 39 citations

Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies

Greg Coffey, Jiajia Feng, Andreas Betz et al. · Clinical Cancer Research · 2018 · 38 citations